Sarcopenia
Conditions
Brief summary
Sarcopenia is an age-related progressive skeletal muscle disease, the prevalence of which is increasing year by year with the aging of China's population, seriously affecting the health and quality of life of the elderly. Relevant studies have shown that protein intake in combination with resistance exercise can significantly improve muscle mass and function, and the effect is superior to that of a single intervention. In addition, ingredients such as vitamin D, N-acetylglucosamine, sodium hyaluronate, and taurine can further promote muscle health by regulating metabolism and inflammation levels. However, there are relatively few intervention studies combining the above nutrients with resistance exercise in patients with sarcopenia. Therefore, this study intends to use protein powder containing milk protein, vitamin D, N-acetylglucosamine, sodium hyaluronate, taurine and other ingredients, combined with low-intensity resistance exercise, to intervene in the middle-aged and elderly patients with sarcopenia, and to explore and observe the effects on muscle mass, bone density, intestinal health and other indexes of patients with sarcopenia, with the aim of providing a more accurate nutritional and exercise intervention program for the prevention and treatment of sarcopenia.
Interventions
DIETARY_SUPPLEMENTProtein powder intervention
On the basis of a balanced diet, 2 sachets of Aiben Leap Protein Nutritional Powder (each sachet containing 6g of milk protein) were supplemented daily.
BEHAVIORALResistance exercise intervention
Low-intensity resistance training was conducted 3 times a week.
DIETARY_SUPPLEMENTPlacebo control
placebo was given and an individualized balanced dietary plan based on the Dietary Guidelines for Chinese Residents was provided.
Sponsors
Beijing Jishuitan Hospital, Capital Medical University
Capital Medical University
Beijing Friendship Hospital
Weiwei Ma
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
35 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Meet the diagnostic criteria for sarcopenia AWGS 2019 1. Grip strength less than 28.0 kg for males and less than 18.0 kg for females 2. 6-meter stride speed less than 1.0 m/s or 5-repetition sit-up test time ≥ 12 seconds or SPPB ≤ 9 points. 3. Bioelectrical Impedance Analysis (BIA) less than 7.0 kg/m² for males and 5.7 kg/m² for females or Dual-energy X-ray absorptiometry (DXA) less than 7.0 kg/m² for males and 5.4 kg/m² for females; * Age between 35-75 years old with high compliance; * Complete clinical data; * Voluntary participation in the program with informed consent and signing of the informed consent form.
Exclusion criteria
* A clear history of allergy to protein powder in the past 6 months, or the presence of diarrhea symptoms and the frequency of ≥ 7 days / month, the duration of more than 2 weeks; * Major physical diseases (diabetes with serious complications, malignant tumors, serious cardiovascular disease, neurological diseases or other diseases that may affect the effectiveness of exercise and nutritional interventions, etc.); * The past three months, new fractures and recently underwent joint replacement surgery patients; * Suffering from congenital bone or muscle diseases; * The simultaneous existence of other comorbidities affecting muscle metabolism, such as malignant tumors, liver disease, severe organ insufficiency such as nephrotic syndrome, renal failure and other diseases that may affect protein metabolism; * Participating in other clinical trials patients; * With sensory disabilities or other reasons significantly affecting the collection of data, such as severe deafness, blindness, mental disorders, etc.; * The researchers The researchers believe that other reasons are not suitable for clinical trials.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Extremity Skeletal Muscle Mass Index (ASMI) | Baseline, month 3, month 6 | ASM was measured using BIA, ASMI=ASM/height (m)\^2. |
| Handgrip strength | Baseline, month 3, month 6 | Maximum force grip was held for 3 seconds, the right and left hands were measured alternately, 3 measurements were taken in each hand, and the maximum value was taken. |
| 6m walking speed | Baseline, month 3, month 6 | Let the tester start from the starting point, walk 6 meters at normal walking speed, stop when reaching the end point, record the time used, and calculate the 6m walking speed according to the time used and the distance of 6 meters. |
| Chair sitting and standing test | Baseline, month 3, month 6 | The subject sat in the center of the chair, crossed his/her arms in front of his/her chest, and after hearing the command start, he/she completed 5 consecutive times of standing up and sitting down, and recorded the total time in seconds. |
| Simple Physical Performance Battery (SPPB) | Baseline, month 3, month 6 | The SPPB consists of 3 test items, each item is scored out of 4 points, and the total score is 12. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Body composition | Baseline, month 6 | Using a human body composition analyzer to detect indicators such as total score, visceral fat area, body segment fat and basal metabolic rate, body cell mass, and limb skeletal muscle mass index. |
| Assessment of ability to perform activities of daily living | Baseline, month 3, month 6 | The ADL was assessed using the Activity of Daily Living Scale (ADL), which consists of 10 items, including eating, bathing, grooming, dressing, bowel control, urination control, toileting, bed and chair transfers, walking, and walking up and down stairs. The total score is 100, with a score of more than 60 indicating mild functional impairment but basic self-care in daily life; a score of 60-41 indicating moderate functional impairment and need for some assistance in daily life; a score of 40-21 indicating severe functional impairment and obvious need for dependence on others in daily life; and a score of less than 20 indicating complete disability and total dependence on others in daily life. |
| Sleep assessment | Baseline, month 3, month 6 | The PSQI (Pittsburgh Sleep Quality Index) questionnaire was used to assess the quality of the subjects' sleep during the last 1 month. It consists of 19 self-assessment and 5 other-assessment entries, of which the 19th self-assessment and 5 other-assessment entries are not involved in scoring. The cumulative score of each component is the total PSQI score, which ranges from 0 to 21, with higher scores indicating poorer sleep quality. |
| Analysis of dietary intake | Baseline, month 6 | The 3-day, 24-hour dietary recall method was used to investigate the subjects' dietary intake. The survey process was supplemented with tools such as the Retrospective Dietary Survey Auxiliary Chart to help the subjects accurately recall their dietary intake. Based on the Standardized Version of the Chinese Food Composition Table (6th Edition), the energy and various types of protein, fat and carbohydrate intake of the population were calculated, and for the missing data in the Chinese Food Composition Table, the United States Department of Agriculture Food Composition Table was used to supplement the data, so as to build up a comprehensive database of dietary intake. The analysis of dietary intake included the intake of total fat, total protein, total carbohydrates and energy and its percentage in the total energy intake. |
| Assessment of overall cognitive functioning | Baseline, month 6 | Subjects were assessed for overall cognitive functioning using the Montreal cognitive assessment (MoCA) scale out of 30, which contains cognitive functioning tests in multiple dimensions of visuospatial and executive functioning, naming, memory, attention, language, abstraction, delayed recall, and orientation.The normal threshold is usually ≥ 26 points, 21-25 points indicate mild cognitive impairment, and ≤ 20 points may indicate dementia risk |
| Bone density | Baseline, month 6 | Bone density, lumbar spine bone density (lumbar 2 - lumbar 4) and left femoral neck bone density are examined using the dualenergy X-ray absorptiometry (DXA) method. |
| Knee joint ultrasound | Baseline, month 6 | Ultrasound was used to examine the knee joint cavity for fluid or synovial hyperplasia and the tendon ligaments and muscles around the knee joint for damage. |
| General survey | Baseline, month 6 | Using a questionnaire designed by the research team and validated by the previous study, the survey covered the age, gender, ethnicity, marital status, occupation, education level, place of residence, household income, living status (living alone and with family), dietary habits and application of nutritional supplements, lifestyle (smoking, drinking, and physical activity), family history, and chronic diseases (hypertension, diabetes, etc.) of the study participants, Hyperlipidemia, etc.) |
| Serum sarcopenia related factors | Baseline, month 6 | Detect serum calcium (Ca), phosphorus (P), serum hydroxyvitamin D (25(OH)D), serum parathyroid hormone (PTH), P-alkaline phosphatase (ALP), serum osteocalcin (OC), serum type 1 pro-collagen N-terminal pre-peptide, serum type 1 collagen cross-linking N-terminal peptide (NTX), and serum anti-tartrate acid phosphatase 5b (TRACP-5b), estradiol (E2), leptin (LP), and so on. |
| Blood lipid concentration | Baseline, month 6 | Determine the serum levels of blood lipid concentration in the population. Lipid tests include total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C). |
| Blood glucose concentration | Baseline, month 6 | Blood glucose tests are fasting blood glucose. |
| Insulin concentration | Baseline, month 6 | Measurement of insulin secretion level. |
| Inflammation-related biochemical indicators | month 6 | Detecting inflammatory cytokine concentration: including TNF-α, IL-1 α, IL-1 β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-10 and other inflammatory factors. |
| Detection of intestinal flora species, quantity and differentiation level in human population | month 6 | The collected feces were subjected to 16S rRNA sequencing technology to detect the diversity of gut microbiota. |
| Knee injury and osteoarthritis outcome score (KOOS score) | Baseline, month 3, month 6 | The KOOS rating includes five independent evaluation dimensions, each calculated separately and converted into a percentage scale (0-100 points, with higher scores indicating better functionality) |
| Height | Baseline, month 3, month 6 | Measure the height of the subjects |
| Weight | Baseline, month 3, month 6 | Measure the weight of the subjects |
| Body Mass Index(BMI) | Baseline, month 6 | Calculate BMI using height and weight , BMI=weight/(height)\^2 |
| Waist circumference, hip circumference, and waist to hip ratio | Baseline, month 3, month 6 | Measure the waist and hip circumference of the subjects and calculate the waist to hip ratio (waist circumference/hip circumference). |
Countries
China
Contacts
Primary ContactWeiwei Ma
Outcome results
None listed